Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.
2.

Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan.

Ogihara T, Arakawa K.

J Hum Hypertens. 1999 Jan;13 Suppl 1:S27-31; discussion S33-4. Review.

PMID:
10076918
3.
4.

Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.

Sever PS.

J Hypertens Suppl. 1997 Dec;15(6):S9-12. Review.

PMID:
9493121
5.

Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.

Sever P.

J Hum Hypertens. 1997 Sep;11 Suppl 2:S91-5. Review.

PMID:
9331018
6.

Candesartan cilexetil: an angiotensin II-receptor blocker.

See S, Stirling AL.

Am J Health Syst Pharm. 2000 Apr 15;57(8):739-46. Review.

PMID:
10786259
7.

Candesartan cilexetil. A review of its use in essential hypertension.

McClellan KJ, Goa KL.

Drugs. 1998 Nov;56(5):847-69. Review.

PMID:
9829158
8.

Efficacy and tolerability of candesartan cilexetil in special patient groups.

Trenkwalder P.

Blood Press Suppl. 2000;1:27-30. Review.

PMID:
11059633
9.
10.

Achieving quality 24-h blood pressure control with candesartan cilexetil.

Meredith P.

Blood Press Suppl. 2000;1:23-6. Review.

PMID:
11059632
11.

Candesartan cilexetil: an angiotensin II receptor blocker.

Stoukides CA, McVoy HJ, Kaul AF.

Ann Pharmacother. 1999 Dec;33(12):1287-98. Review.

PMID:
10630830
12.
13.
14.

Improving antihypertensive efficacy while maintaining placebo-like tolerability.

Sever PS.

Blood Press Suppl. 2000;1:19-22. Review.

PMID:
11059631
15.

Candesartan cilexetil: an update of its use in essential hypertension.

Easthope SE, Jarvis B.

Drugs. 2002;62(8):1253-87. Review.

PMID:
12010090
16.

Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.

Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T.

J Hum Hypertens. 1999 Jan;13 Suppl 1:S75-80. Review.

PMID:
10076925
17.

Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension.

Hoy SM, Keating GM.

Am J Cardiovasc Drugs. 2010;10(5):335-42. doi: 10.2165/11206300-000000000-00000. Review.

PMID:
20860416
18.

[Angiotensin receptor antagonist for therapy of patients with hypertension].

Rakugi H, Ogihara T.

Nihon Rinsho. 1997 Aug;55(8):2075-80. Review. Japanese.

PMID:
9284426
20.

[Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].

Bramlage P, Schönrock E, Odoj P, Wolf WP, Funken C.

MMW Fortschr Med. 2008 Feb 7;150(6):40. Review. German. No abstract available.

PMID:
18323344

Supplemental Content

Support Center